Related Experiment Video
Updated: Aug 5, 2025

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
Published on: May 30, 2020
In Search of Clinical Markers: Indicators of Exposure in Dampness and Mold Hypersensitivity Syndrome (DMHS)
Kirsi Vaali1, Kingsley Mokube Ekumi1, Maria A Andersson2,3
1Department of Pathology, Medicum, University of Helsinki, 00290 Helsinki, Finland.
Abstract:
Potential markers were sought to diagnose mold hypersensitivity. Indoor air condensed water and human macrophage THP-1 test were applied to evaluate the buildings. Basophil activation tests (BAT) were conducted and mold-specific immunoglobulins (IgE, IgG, IgA, and IgD) were measured in study subjects' serum and feces. Exposed subjects reported markedly more symptoms from occupational air than controls. Basophils from exposed subjects died/lost activity at 225 times lower concentrations of toxic extracts from the target building than recommended in the common BAT protocol. Fecal IgG and IgD levels against Acrostalagmus luteoalbus and Aspergillus versicolor produced receiver operating curves (ROC) of 0.928 and 0.916, respectively, when plotted against the inflammation marker MRP8/14. Assaying serum immunoglobulin concentrations against the toxic Chaetomium globosum (MTAV35) from another building, a test control, did not differentiate study individuals. However, if liver metabolism produced the same core molecule from other Chaetomium globosum strains, this would explain the increased response in fecal immunoglobulins in the exposed. The altered immunoglobulin values in the samples of exposed when compared to controls revealed the route of mold exposure. The toxicity of indoor air condensed water samples, BAT and serology confirmed the severity of symptoms in the target building's employees, supporting earlier findings of toxicity in this building.
Insights
Researchers identified novel fecal immunoglobulin markers (IgG, IgD) for diagnosing mold hypersensitivity. These markers, alongside basophil activation tests, confirm indoor mold toxicity and associated health symptoms.
Area of Science:
- Environmental Health
- Immunology
- Occupational Medicine
Background:
- Mold exposure in indoor environments is linked to hypersensitivity and adverse health effects.
- Accurate diagnostic markers for mold hypersensitivity are needed to assess building-related illnesses.
- Previous studies indicated toxicity in specific indoor air environments, necessitating further investigation.
Purpose of the Study:
- To identify potential biomarkers for diagnosing mold hypersensitivity.
- To evaluate the diagnostic utility of mold-specific immunoglobulins and basophil activation tests (BAT).
- To correlate biological markers with reported symptoms and environmental toxicity.
Main Methods:
- Analysis of indoor air condensed water and human macrophage THP-1 cell tests.
- Conducting basophil activation tests (BAT) and measuring mold-specific immunoglobulins (IgE, IgG, IgA, IgD) in serum and feces.
- Utilizing receiver operating characteristic (ROC) curves to assess marker performance against inflammation markers (MRP8/14).
Main Results:
- Exposed subjects reported significantly more symptoms compared to controls.
- Basophils from exposed subjects showed heightened sensitivity to toxic mold extracts.
- Fecal IgG and IgD levels against specific molds demonstrated high diagnostic accuracy (ROC > 0.9) for inflammation.
Conclusions:
- Fecal immunoglobulin profiles can serve as reliable indicators of mold exposure and hypersensitivity.
- BAT and serological assays, combined with environmental assessments, confirm the severity of mold-induced health issues.
- Findings support the link between indoor mold toxicity and occupational health symptoms, validating diagnostic approaches.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Heart Failure III: Clinical Manifestations
Hypertension III: Clinical Manifestations and Diagnostic Studies
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History

